Imidapril
- Generic Name
- Imidapril
- Drug Type
- Small Molecule
- Chemical Formula
- C20H27N3O6
- CAS Number
- 89371-37-9
- Unique Ingredient Identifier
- BW7H1TJS22
Overview
Imidapril has been investigated for the treatment of Kidney, Polycystic, Autosomal Dominant.
Background
Imidapril has been investigated for the treatment of Kidney, Polycystic, Autosomal Dominant.
Indication
用于治疗原发性高血压、肾实质性病变所致的继发性高血压。
Associated Conditions
- Hypertension, Essential Hypertension
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
TANATRIL TABLETS 10 mg
Manufacturer:PT Mitsubishi Tanabe Pharma Indonesia
Form:TABLET
Strength:10 mg
Online:Yes
Approved: 1999/01/06
Approval:SIN10614P
TANATRIL TABLETS 5 mg
Manufacturer:PT Mitsubishi Tanabe Pharma Indonesia
Form:TABLET
Strength:5 mg
Online:Yes
Approved: 1999/01/06
Approval:SIN10615P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath